As combination products such as prefilled syringes (PFS), auto-injectors, and drug-device delivery systems continue to expand within the pharmaceutical industry, ensuring reliable Container Closure Integrity Testing (CCIT) has become increasingly critical for sterility assurance, product stability, and patient safety.

Hematolymphoid malignancies are characterized by complex genomic landscapes that include single nucleotide variants, small and large insertions and deletions, copy number changes, and oncogenic gene fusions. Increasingly, laboratories are adopting comprehensive genomic profiling (CGP)–style approaches to interrogate both DNA- and RNA‑level alterations in a unified workflow, supporting discovery, classification, and translational research in hematologic cancers.

With citations in more than 1,600 publications and adoption by scientists worldwide, mass photometry is transforming biomolecular analysis.

Discover validated research workflows for analyzing low-frequency cfDNA mutations and generating epigenetic profiles across liquid biopsy and biomarker applications.

Laboratories are under increasing pressure to control costs, maximize labor efficiency, and scale testing sustainably, while still delivering accurate detection of repeat expansions, homologous genes, and other complex genomic regions.